Open, Single-arm, Multicenter, Phase II Trial Investigating the Safety of Biweekly Cabazitaxel in Metastatic Castration Resistant Prostate Cancer Patients Previously Treated With a Docetaxel-containing Regimen.
Phase of Trial: Phase II
Latest Information Update: 24 Oct 2016
At a glance
- Drugs Cabazitaxel (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- Acronyms ProstyII
- 07 Jun 2016 Status changed from recruiting to completed as results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology
- 31 Mar 2012 New source identified and integrated (European Clinical Trials Database, EudraCT2011-003156-39).
- 26 Mar 2012 New trial record